UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors

Not Applicable

Recruiting

Conditions: Gut Microbiome
Exercise
Fatigue
Breast Cancer

Interventions: Other: Aerobic Exercise Training
Other: Attention Control

First Posted Date: 2019-09-13

Last Posted Date: 2024-04-12

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 126

Registration Number: NCT04088708

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

Phase 1

Completed

Conditions: Metastatic Prostate Cancer

Interventions: Drug: [68Ga]PSMA-PET/MRI or PET/CT

First Posted Date: 2019-09-12

Last Posted Date: 2024-04-26

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 10

Registration Number: NCT04086966

Locations: 🇺🇸
University of Alabama at Birmingham Medical Center, Birmingham, Alabama, United States

Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting

Phase 2

Withdrawn

Conditions: Chemotherapy-induced Nausea and Vomiting

Interventions: Drug: GRANISETRON EXTENDED RELEASE INJECTION (GERSC)

First Posted Date: 2019-09-11

Last Posted Date: 2020-09-30

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT04085393

Locations: 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States

Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)

Early Phase 1

Recruiting

Conditions: Influenza, Human

Interventions: Biological: Treatment Group Live Attenuated Flu Vaccine (LAIV)

First Posted Date: 2019-09-06

Last Posted Date: 2024-08-01

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 18

Registration Number: NCT04080245

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Ketone Supplementation in Adolescents Post-Concussion

Not Applicable

Completed

Conditions: Concussion, Mild
Concussion, Severe
Sports Injuries in Children
Concussion, Brain
Concussive Injury
Sport Injury

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Ketone

First Posted Date: 2019-09-06

Last Posted Date: 2022-05-10

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 5

Registration Number: NCT04079907

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Regional Block for Postoperative Free Flap Care

Phase 4

Completed

Conditions: Pain Management

Interventions: Drug: ropivicaine 0.2%

First Posted Date: 2019-09-06

Last Posted Date: 2023-12-06

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 100

Registration Number: NCT04080739

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Gout in the ED and Improving Research Participation

Not Applicable

Active, not recruiting

Conditions: Gout

Interventions: Behavioral: Storytelling

First Posted Date: 2019-09-03

Last Posted Date: 2024-12-09

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 280

Registration Number: NCT04075903

Locations: 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
MetroHealth Medical Center, Cleveland, Ohio, United States

and more 1 locations

Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis

Not Applicable

Recruiting

Conditions: Cystic Fibrosis

Interventions: Behavioral: Behavioral Counseling and Exercise

First Posted Date: 2019-09-03

Last Posted Date: 2024-12-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT04075864

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

The Multicenter Topic Trial

Phase 2

Withdrawn

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Ivacaftor

First Posted Date: 2019-08-26

Last Posted Date: 2022-01-27

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT04066751

Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study

Not Applicable

Completed

Conditions: Restless Legs Syndrome
Multiple Sclerosis

Interventions: Behavioral: Behavioral Intervention (BIPAMS)

First Posted Date: 2019-08-20

Last Posted Date: 2020-12-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 15

Registration Number: NCT04061681

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy